BCRB 2018

Combined chemo- and radiotherapy treatment • “Objective-oriented” design of clinical trials • Benefit of RT+Chemo is due to tissular interaction • Anti-proliferation-based efficacy and toxicity • More data needed to design combined RT+Chemo trial based on cellular/molecular interaction • Equal dose trial <> equal toxicity trial

ESTRO 2018